Author Correction: Targeting public neoantigens for cancer immunotherapy (Nature Cancer, (2021), 2, 5, (487-497), 10.1038/s43018-021-00210-y)

Alexander H. Pearlman, Michael S. Hwang, Maximilian F. Konig, Emily Han Chung Hsiue, Jacqueline Douglass, Sarah R. DiNapoli, Brian J. Mog, Chetan Bettegowda, Drew M. Pardoll, Sandra B. Gabelli, Nicholas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Shibin Zhou

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the version of this article initially published, the seventh label along the vertical axis of Fig. 3 (IDH1 p.Arg132Cys) was incorrect, and ten labels (TCGA project names) along the horizontal axis of Fig. 3 were not in the correct order. The correct label along the vertical axis is ‘KRAS p.Gly12Cys’, and the correct order for labels along the horizontal axis is now provided. The errors have been corrected in the HTML and PDF versions of the article.

Original languageEnglish (US)
Pages (from-to)865-867
Number of pages3
JournalNature Cancer
Volume2
Issue number8
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Author Correction: Targeting public neoantigens for cancer immunotherapy (Nature Cancer, (2021), 2, 5, (487-497), 10.1038/s43018-021-00210-y)'. Together they form a unique fingerprint.

Cite this